- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01010165
Determination of New Biomarkers of Septic Arthritis by Surface-Enhanced Laser Desorption/Ionization Time-Of-Flight (SELDI-TOF) (NOUBASST)
Caractérisation de Nouveaux Biomarqueurs de l'Arthrite Septique Par Technique SELDI-TOF
Septic arthritis is a frequent, potentially disabling and/or life-threatening disease. To diagnose a septic arthritis is a complex procedure, first because of numerous differential diagnoses (such as crystal arthritis), second because of poor sensitivity of initial gram staining (for example after untimely antibiotic therapy).
This protocol will use SELDI-TOF as a tool to analyse joint fluid of patients with various acute, polymorphonuclear-rich arthritis, as to determine specific and sensitive new biomarkers of a septic origin.
Such biomarkers will allow rapid diagnosis of septic arthritis in the first hours of admission.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Grenoble, France, 38000
- University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- acute arthritis (onset not more than 7 days ago)
- joint fluid leukocyte count : more than 2000/mm3, more than 50% polymorphonuclear
Exclusion Criteria:
- none (apart from unability to accept inclusion)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
septic arthritis
|
crystal arthritis
|
rheumatismal disease
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: olivier epaulard, MD, PhD, University Hospital, Grenoble
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0916
- 2009-A00810-57 (Registry Identifier: RCB)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Arthritis
-
Guangdong Provincial Hospital of Traditional Chinese...RecruitingAcute Pain | Acupuncture | Acute Gout ArthritisChina
-
Prof. Dr. Ulrich HeiningerLuzerner KantonsspitalCompletedSeptic Arthritis | Acute Haematogenous OsteomyelitisSwitzerland
-
San Antonio Uniformed Services Health Education...UnknownPain, Postoperative | Osteo Arthritis Knee | Pain, Acute
-
Alloksys Life Sciences B.V.Aix ScientificsCompletedAcute Rheumatoid ArthritisUnited Kingdom
-
The Methodist Hospital Research InstituteCompleted
-
Novilla PharmaceuticalsNot yet recruitingAcute Pain | Gout Flare | Acute Gouty ArthritisAustralia
-
DePuy OrthopaedicsTerminatedOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Acute FractureUnited States
-
Novartis PharmaceuticalsCompletedAcute Gouty Arthritis FlaresUnited States, Estonia, Lithuania, Germany, Russian Federation, Canada, Australia, Latvia, Ukraine
-
Swedish Orphan BiovitrumCompletedAcute Gouty ArthritisUnited States
-
Beijing University of Chinese MedicineUnknown